/ Print /

Pharmacy

Can Amazon change the pharmacy landscape?Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Top 3 strategies employers should use to decrease healthcare costsA new Willis Towers Watson survey finds that U.S. employers have three key strategies to building cost-effective healthcare programs. 
Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
One plan’s unique approach to combat diabetes, obesityThis novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Four steps managed care can take to promote antimicrobial stewardshipThe call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era.
Prescribing practices that increase risk of opioid overdoseTwo studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.
Prevent polypharmacy problemsPolypharmacy presents real problems—especially for older adults.
Insulin treatment persistence varies among payersA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.
Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.